Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 2 1

Status

Completed 33Active not recruiting 8Terminated 6Unknown 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 114OTHER_GOV 6INDUSTRY 4NIH 3UNKNOWN 1NETWORK 1INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Head & Neck 1CNS 1

Conditions

Neoplasms 2Thyroid Diseases 1Oligodendroglioma 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Injections 53Cisplatin 47Paclitaxel 46Carboplatin 41Gemcitabine 37Docetaxel 36Capecitabine 36pembrolizumab 35Drug Therapy 34anlotinib 25icotinib 23Fluorouracil 23Bevacizumab 23Cyclophosphamide 22Oxaliplatin 19fludarabine 18Pemetrexed 17Irinotecan 16Leucovorin 15Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 11Rituximab 11Etoposide 11tesetaxel 10SHR-1701 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Surgical Procedures, Operative × Clear all
NCT01637753 2012-07-11

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase NA Unknown
212 enrolled
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT01574729 2012-06-28

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 2 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00902083 2012-04-09

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Tumor-Agnostic

Neoplasms

NCT00902122 2012-04-09

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Head & Neck

Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡